Charles Sawyers in the opening plenary #AACR26 about lineage transition upon antiandrogen therapy in prostate cancer (from PRAD into a neuroendocrine state). Identifying a role for Yap-TEAD activity driving lineage plasticity & proposing targets for lineage restitution therapy.